Industry News
Related Searches:
Filter by:
September 30, 2009
Hospira, Inc. has acquired worldwide rights to a biogeneric version of filgrastim and an affiliated manufacturing facility from PLIVA Hrvatska in Zagreb, Croatia.
Read More »
September 30, 2009
Almac has plans for a major expansion at its Craigavon headquarters and has acquired a 5.4-acre site for the first phase of development.
Read More »
September 30, 2009
Covance, Inc. has added cGMP melamine testing services in North America to meet recent FDA guidance on melamine testing for pharmaceutical and animal health manufacturers.
Read More »
September 29, 2009
Catalent Pharma Solutions and GlaxoSmithKline (GSK) have extended their contract under which Catalent will continue to supply GSK with its trade requirements of Lovaza omega-3 acid ethyl esters in soft gelatin capsules.
Read More »
September 29, 2009
Patheon has opened a new Pharmaceutical Development Services (PDS) manufacturing site for investigational medical products within its existing manufacturing facility in Ferentino, Italy.
Read More »
September 29, 2009
Laureate Pharma has entered into a development and manufacturing agreement with ZZ Biotech, LLC, under which Laureate will produce Activated Protein C variant under cGMP conditions.
Read More »
September 29, 2009
West Pharmaceutical Services, Inc. has opened its new 129,000-sq.-ft. injection-molding factory in the Shanghai Qingpu Industrial Zone (SQIZ) in China.
Read More »
September 29, 2009
Vetter recently inaugurated its Ravensburg South site with a new 862,000 sq.-ft. area that now includes facilities for the aseptic filling and packaging of injectable drugs.
Read More »
September 28, 2009
Abbott has entered a definitive agreement with the Solvay Group to acquire Solvay's pharmaceuticals business for $6.6 billion in cash.
Read More »
September 28, 2009
Johnson & Johnson, through its subsidiary Ortho-McNeil-Janssen Pharmaceuticals, Inc., and Crucell have entered into a strategic collaboration for the discovery, development and commercialization of monoclonal antibodies and vaccines for the treatment and
Read More »
September 22, 2009
Pfizer and Wyeth have entered into an agreement with Boehringer Ingelheim to divest certain animal health assets, pending Pfizer’s acquisition of Wyeth.
Read More »
September 22, 2009
Toxikon Corp. has expanded its immunotoxicology offerings, adding flow cyctometry, which enables the direct analysis of cells to detect a variety of specifically labeled components.
Read More »
September 21, 2009
DOR BioPharma has been awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH).
Read More »
September 21, 2009
Anavex Life Sciences Corp. has completed the scale-up manufacturing of Anavex 2-73, its lead compound for the treatment of Alzheimer's disease.
Read More »
September 17, 2009
ICON has received industry accreditations for three of its laboratories.
Read More »
